Restoring ventricular restoration: A call to re-evaluate a surgical therapy considered ineffective

Torsten Doenst1, Eric J Velazquez2, Robert E Michler3

  • 1Department of Cardiothoracic Surgery, Friedrich-Schiller-University of Jena, University Hospital Jena, Jena, Germany.

Insights

Surgical restoration of postischemically dilated left ventricles (SVR) is under scrutiny after the STICH trial. A new analysis aims to re-evaluate SVR

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Ischemic Heart Disease Management

Background:

  • The Surgical Treatment of IsChemic Heart failure (STICH) Trial reported no benefit for surgical restoration of postischemically dilated left ventricles (SVR) in patients with coronary artery disease (CAD) and low ejection fraction.
  • Criticism suggests the STICH trial's patient selection and surgical expertise may have limited its ability to assess SVR's true potential, particularly in aneurysm patients.

Purpose of the Study:

  • To address the controversy surrounding the STICH trial's findings on SVR.
  • To propose and justify a new analysis comparing STICH patients with a cohort of SVR patients treated by an expert center.

Main Methods:

  • The proposed study will compare the patient population from the STICH trial with a comparable group of SVR patients.
  • The comparison group will consist of patients treated at a center with documented expertise in SVR.

Main Results:

  • The abstract does not contain specific results, but discusses the rationale for a future analysis.

Conclusions:

  • The proposed comparative analysis has the potential to provide valuable insights into the efficacy of SVR.
  • Re-evaluating SVR with improved patient selection and surgical expertise may clarify its role in treating ischemic heart failure.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
125
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
115
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
124
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
175
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
109
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
96